Prevalence of colistin resistance of Klebsiella pneumoniae isolates in Iran: a systematic review and meta-analysis

Abstract Objective Klebsiella pneumoniae is a gram-negative pathogen common cause of nosocomial infections. Colistin is a last resort antibiotic to treat infections caused by K. pneumoniae. In recent years, the resistance rate to colistin has increased in K. pneumoniae. This study evaluated the prev...

Full description

Saved in:
Bibliographic Details
Main Authors: Negar Narimisa (Author), Forough Goodarzi (Author), Shirin Bavari (Author)
Format: Book
Published: BMC, 2022-06-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_ffe04ce220e74c69b74dc7ca35b9fe9a
042 |a dc 
100 1 0 |a Negar Narimisa  |e author 
700 1 0 |a Forough Goodarzi  |e author 
700 1 0 |a Shirin Bavari  |e author 
245 0 0 |a Prevalence of colistin resistance of Klebsiella pneumoniae isolates in Iran: a systematic review and meta-analysis 
260 |b BMC,   |c 2022-06-01T00:00:00Z. 
500 |a 10.1186/s12941-022-00520-8 
500 |a 1476-0711 
520 |a Abstract Objective Klebsiella pneumoniae is a gram-negative pathogen common cause of nosocomial infections. Colistin is a last resort antibiotic to treat infections caused by K. pneumoniae. In recent years, the resistance rate to colistin has increased in K. pneumoniae. This study evaluated the prevalence of colistin resistance of K. pneumoniae isolates in Iran using a systematic review and meta-analysis. Method A systematic search was performed for relevant articles until August 2021 in the following database: PubMed, Scopus, SID and Google Scholar. The pooled prevalence of colistin resistance in clinical K. pneumoniae isolates analyzed using Comprehensive Meta-Analysis Software (CMA). Results Finally, 19 articles with appropriate criteria were included in the meta-analysis. Our results showed 6.9% of the pooled prevalence of colistin resistance in clinical K. pneumoniae isolates in Iran. The results of subgroup analysis demonstrated increase resistance of colistin from 4.8%; (95% CI 1.5-13.9%) in 2013-2018 to 8.2%; (95% CI 3.4-18.6%), in 2019-2021. Also, the results of our study showed a strong association between the carbapenem producing K. pneumoniae and increased resistance to colistin. Conclusions This study showed a high prevalence of colistin resistance in K. pneumoniae isolates. It is recommended that regular evaluation be performed to control colistin resistance. 
546 |a EN 
690 |a Klebsiella pneumoniae 
690 |a Antibiotic resistance 
690 |a Colistin 
690 |a Meta analysis 
690 |a CMA 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
690 |a Infectious and parasitic diseases 
690 |a RC109-216 
690 |a Microbiology 
690 |a QR1-502 
655 7 |a article  |2 local 
786 0 |n Annals of Clinical Microbiology and Antimicrobials, Vol 21, Iss 1, Pp 1-9 (2022) 
787 0 |n https://doi.org/10.1186/s12941-022-00520-8 
787 0 |n https://doaj.org/toc/1476-0711 
856 4 1 |u https://doaj.org/article/ffe04ce220e74c69b74dc7ca35b9fe9a  |z Connect to this object online.